Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Cancer Immunology, Immunotherapy : CII|February 6, 2019
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinomaSandra P D'Angelo, Matthias Hunger, Andrew S Brohl, et al.
Frontiers in Neuroengineering|May 13, 2011
Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicalsA Novellino, Bibiana Scelfo, T Palosaari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical OutcomeEvan Rosenbaum, Kenneth Seier, Chaitanya Bandlamudi, et al.
Journal for Immunotherapy of Cancer|September 29, 2024
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analysesNathan D Seligson, James L Chen, Austin C Goodrich, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 12, 2017
Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcomaNeel P Chudgar, Murray F Brennan, Rodrigo R Munhoz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 18, 2023
Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent eventsR Bissonnette, L F Eichenfield, E Simpson, et al.
Cancer Medicine|June 21, 2026
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II TrialsAdel Shahnam, Kristen DiConza, Simran Jasnani, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2015
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomasMrinal Gounder, Ved Desai, Deborah Kuk, et al.
Journal for Immunotherapy of Cancer|May 17, 2020
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trialSandra P D'Angelo, Shailender Bhatia, Andrew S Brohl, et al.
Cancer Research Communications|October 3, 2023
Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced SarcomasEvan Rosenbaum, Kenneth Seier, Martina Bradic, et al.
Pageof 16